查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048153

自動化凝血系統市場 - 全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

Automatic Coagulation System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球自動化凝血測量系統市場預計將從 2025 年的 28.1 億美元成長到 2031 年的 41.6 億美元，複合年成長率為 6.76%。

該市場涵蓋了旨在自動測量血液凝固參數的先進診斷設備，這些參數對於評估止血功能至關重要。該市場的成長主要受出血性和血栓性疾病日益普遍的驅動，這些疾病需要在臨床環境中病患監測。此外，根據國際血栓與止血學會 (ISTH) 的預測，到 2024 年，全球四分之一的死亡病例將與血栓性疾病相關，因此，檢查室正擴大採用這些自動化解決方案來簡化工作流程並應對不斷成長的實驗室工作量。儘管成長趨勢良好，但由於這些高性能系統需要大量的資本投資，該市場仍面臨巨大的挑戰。高昂的實施成本和持續的維護成本可能會阻礙小規模醫療機構和發展中地區的基礎設施升級，從而限制其市場滲透率。因此，預算限制仍然是這些關鍵診斷技術廣泛應用的主要障礙。

市場概覽
預測期 2027-2031
市場規模：2025年 28.1億美元
市場規模：2031年 41.6億美元
複合年成長率：2026-2031年 6.76%
成長最快的細分市場 全自動
最大的市場 北美洲

市場促進因素

止血功能障礙和心血管疾病日益成長的普遍是全球自動化血液凝固檢驗系統市場的主要驅動力。這些疾病需要嚴格且頻繁的血液凝固評估，以預防嚴重甚至危及生命的併發症。臨床醫生高度依賴自動化凝血分析儀來監測接受抗凝血治療的患者，並診斷心臟病和中風相關的複雜凝血功能障礙。近期死亡率統計數據印證了這種日益加重的臨床負擔，凸顯了診斷準確性的關鍵性。例如，根據美國心臟協會於2025年1月發布的《2025年心臟病和中風統計數據更新》，心血管疾病仍是美國的主要死因，佔2022年所有死亡人數的39.5%。如此高的死亡率推動了醫院和實驗室對專業止血檢測能力的持續需求，以有效管理患者的治療效果。同時，檢查室處理能力的需求顯著成長，加速了全自動血液凝固檢驗系統的應用，尤其是在醫療機構面臨嚴重的人員短缺和檢查室量不斷增加的情況下。實驗室正逐步從人工操作轉向利用人工智慧和機器人技術的整合平台，以簡化工作流程並緩解人員短缺問題。這種營運壓力也體現在熟練人員短缺的勞動市場趨勢上。根據美國臨床病理學會 (ASCP) 2025 年 12 月發布的“2024 年職位空缺調查”，在接受調查的 17 個實驗室部門中，有 10 個部門的人員流動率高於以往週期，這進一步增加了對自動化以維持服務水平的需求。這種向自動化解決方案的轉變也反映在市場發展勢頭上，Werfen 公司在 2025 年報告稱，其止血部門在上一會計年度的銷售額成長了 6.6%（不計外匯波動的影響）。

市場挑戰

全球自動化血液凝固檢驗系統市場成長的主要障礙在於高效能診斷系統所需的大量資本投入。除了高昂的初始成本外，持續的維護費用也相當可觀，這對發展中地區的小規模醫療機構構成了重大障礙。這種經濟負擔阻礙了潛在買家升級現有基礎設施，從而限制了市場擴張，並阻礙了自動化止血檢測的廣泛應用。因此，該市場難以滲透到對成本敏感的行業，直接影響了該行業利用日益成長的精準血液凝固分析需求的能力。此外，持續的預算限制加劇了這項挑戰，限制了診斷檢查室的財務柔軟性。根據美國病理學家協會預測，到2025年，檢查室耗材和一般管理費用將增加超過17%，對實驗室預算造成巨大壓力。營運成本的急劇上升迫使檢查室決策者推遲對先進自動化技術的投資。因此，這些經濟壓力直接阻礙了新型凝血分析儀的推出，減緩了全球市場的整體擴張。

市場趨勢

基於試劑盒的黏彈性止血檢測的轉變正在從根本上改變重症監護環境中凝血障礙的管理。臨床醫生越來越傾向於採用全血分析而非傳統的基於血漿的血液凝固檢驗，以便在創傷和大規模外科手術過程中快速、有效地了解凝血的形成和溶解情況。緊湊、易用的試劑盒系統的開發進一步加速了這一轉變，這些系統無需複雜的手動移液操作，可在患者床邊進行檢測，並顯著縮短緊急診斷所需的時間。對專業止血解決方案的強勁需求反映在 Hemonetics 於 2025 年 5 月發布的 2025 會計年度公佈財報中，該報告顯示醫院銷售額成長了 23.7%。這主要得益於 TEG 6s 系統的持續應用以及其試劑盒產品組合的擴展。隨著主要製造商尋求業務的垂直整合，透過併購和合作進行的策略性產業重組正在從根本上改變競爭格局。各公司正加速向直銷模式轉型，打破傳統的銷售合作關係，以確保更高的利潤率並加強與關鍵地區的客戶關係。這種重組使診斷設備製造商能夠管理從生產製造到終端用戶支援的整個價值鏈，從而最佳化商業性效率並應對力市場需求。根據希森美康公司（Sysmex Corporation）於2025年5月發布的“截至2025年3月的會計年度合併概要”，其在歐洲、中東和非洲地區的銷售額同比成長11.6%。這項業績歸功於止血領域銷售管道的成功拓展以及公司策略性地逐步取消第三方分銷協議。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球自動化凝血系統市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（全自動、半自動）
    • 透過申請（醫院、生技公司、診所等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美自動化凝血系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲自動化凝血系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區自動化凝血系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲自動化凝血系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲自動化凝血系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球自動化凝血系統市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Beijing Succeeder Technology, Inc.
  • Cardinal Health, Inc.
  • Dymind Biotechnology Co. Ltd.
  • Erba Group
  • HORIBA, Ltd.
  • Labtron Equipment Ltd
  • Linear Chemicals, SLU
  • Maccura Biotechnology Co., Ltd.
  • Seleo SRL
  • Thermo Fisher Scientific, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27623

The Global Automatic Coagulation System Market is projected to expand from USD 2.81 Billion in 2025 to USD 4.16 Billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 6.76%. This market encompasses advanced diagnostic tools designed to automate the measurement of blood clotting parameters, essential for assessing hemostasis. The market's growth is predominantly fueled by the increasing prevalence of bleeding and thrombotic disorders, which necessitate frequent and accurate patient monitoring in clinical settings. Furthermore, laboratories are increasingly adopting these automated solutions to enhance workflow efficiency and manage growing testing volumes, especially given that one in four global deaths in 2024 were linked to thrombosis-related conditions, as reported by the International Society on Thrombosis and Haemostasis. While growth is positive, the market faces a significant challenge due to the substantial capital investment required for these high-performance systems. The elevated acquisition and ongoing maintenance costs can deter smaller healthcare facilities and developing regions from upgrading their infrastructure, potentially hindering broader market penetration. Consequently, budget constraints remain a primary hurdle impeding the widespread adoption of these critical diagnostic technologies.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.81 Billion
Market Size 2031USD 4.16 Billion
CAGR 2026-20316.76%
Fastest Growing SegmentFully Automatic
Largest MarketNorth America

Market Driver

The rising prevalence of hemostatic and cardiovascular disorders serves as a primary catalyst for the global automatic coagulation system market, as these conditions demand rigorous and frequent blood clotting assessments to prevent severe, life-threatening complications. Clinicians heavily rely on automated coagulation analyzers to monitor patients undergoing anticoagulant therapies and to diagnose complex coagulopathies associated with heart disease and stroke. This escalating clinical burden is underscored by recent mortality statistics, highlighting the critical need for diagnostic precision; for example, the American Heart Association's January 2025 '2025 Heart Disease and Stroke Statistics Update' indicated that cardiovascular disease remained the leading cause of death in the United States, accounting for 39.5% of all deaths in 2022. Such high mortality rates drive a continuous demand for specialized hemostasis testing capabilities in hospitals and reference laboratories to effectively manage patient outcomes. Concurrently, a significant surge in demand for high-throughput laboratory efficiency is accelerating the adoption of fully automated coagulation systems, particularly as healthcare facilities contend with acute workforce shortages and increasing testing volumes. Laboratories are progressively moving away from manual methods towards integrated platforms that leverage artificial intelligence and robotics to streamline workflows and alleviate staffing gaps. This operational strain is evident in workforce trends, showing a contraction in available skilled personnel; according to the American Society for Clinical Pathology's December 2025 '2024 Vacancy Survey,' ten of the 17 laboratory departments surveyed reported rising retirement rates compared with previous cycles, intensifying the need for automation to sustain service levels. This shift towards automated solutions is reflected in the market momentum, with Werfen reporting in 2025 that its Hemostasis division experienced a 6.6% sales increase in constant currency during the previous fiscal year.

Market Challenge

A significant impediment to the growth of the Global Automatic Coagulation System Market is the substantial capital investment required for high-performance diagnostic systems. The elevated costs of acquisition, combined with considerable ongoing maintenance expenses, create a formidable barrier for smaller healthcare facilities and institutions in developing regions. These financial demands discourage potential buyers from upgrading their existing infrastructure, effectively limiting the market's reach and preventing the widespread adoption of automated hemostasis testing. As a result, the market struggles to penetrate cost-sensitive sectors, directly hindering the industry's ability to capitalize on the increasing demand for accurate blood clotting analysis. Furthermore, persistent budget constraints exacerbate this challenge by restricting the financial flexibility of diagnostic laboratories. According to the College of American Pathologists, in 2025, the costs associated with laboratory supplies and general overhead increased by over 17%, placing immense pressure on facility budgets. This stark rise in operational expenditure compels laboratory decision-makers to defer investments in advanced automation technology. Consequently, these economic pressures directly stall the installation of new coagulation analyzers, thereby slowing the overall expansion of the global market.

Market Trends

The shift towards cartridge-based viscoelastic hemostasis testing is fundamentally altering the management of coagulopathies within critical care environments. Clinicians are increasingly prioritizing whole-blood analysis over conventional plasma-based coagulation tests to obtain rapid, actionable insights into clot formation and lysis during trauma and major surgical procedures. This transition is further expedited by the development of compact, user-friendly cartridge systems that eliminate complex manual pipetting, enabling near-patient testing and significantly improving turnaround times for urgent diagnostics. This robust demand for specialized hemostasis solutions is reflected in Haemonetics Corporation's May 2025 'Fiscal Year 2025 Earnings Release,' which reported a 23.7% increase in hospital revenue, driven substantially by the continued adoption of the TEG 6s system and its expanding portfolio of assay cartridges. Strategic industry consolidation through mergers and partnerships is fundamentally reshaping the competitive landscape as major manufacturers move to verticalize their operations. Companies are increasingly dissolving historical distribution alliances in favor of direct sales models to capture higher margins and strengthen customer relationships in key territories. This restructuring allows diagnostic firms to control the entire value chain, from manufacturing to end-user support, thereby optimizing commercial efficiency and responsiveness to market needs. According to Sysmex Corporation's May 2025 'Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025,' sales in the EMEA region rose by 11.6% year-on-year, a performance explicitly attributed to the successful expansion of direct sales channels in the hemostasis field and a strategic pivot away from third-party distribution agreements.

Key Market Players

  • Beijing Succeeder Technology, Inc.
  • Cardinal Health, Inc.
  • Dymind Biotechnology Co. Ltd.
  • Erba Group
  • HORIBA, Ltd.
  • Labtron Equipment Ltd
  • Linear Chemicals, S.L.U.
  • Maccura Biotechnology Co., Ltd.
  • Seleo S.R.L.
  • Thermo Fisher Scientific, Inc.

Report Scope

In this report, the Global Automatic Coagulation System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automatic Coagulation System Market, By Type

  • Fully Automatic
  • Semi-Automatic

Automatic Coagulation System Market, By Application

  • Hospital
  • Biotechnology Company
  • Clinics
  • Others

Automatic Coagulation System Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automatic Coagulation System Market.

Available Customizations:

Global Automatic Coagulation System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Automatic Coagulation System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Fully Automatic, Semi-Automatic)
    • 5.2.2. By Application (Hospital, Biotechnology Company, Clinics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Automatic Coagulation System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Automatic Coagulation System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Automatic Coagulation System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Automatic Coagulation System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Automatic Coagulation System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Automatic Coagulation System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Automatic Coagulation System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Automatic Coagulation System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Automatic Coagulation System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Automatic Coagulation System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Automatic Coagulation System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Automatic Coagulation System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Automatic Coagulation System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Automatic Coagulation System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Automatic Coagulation System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Automatic Coagulation System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Automatic Coagulation System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Automatic Coagulation System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Automatic Coagulation System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Automatic Coagulation System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Automatic Coagulation System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Automatic Coagulation System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Automatic Coagulation System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Automatic Coagulation System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Automatic Coagulation System Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Beijing Succeeder Technology, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cardinal Health, Inc.
  • 15.3. Dymind Biotechnology Co. Ltd.
  • 15.4. Erba Group
  • 15.5. HORIBA, Ltd.
  • 15.6. Labtron Equipment Ltd
  • 15.7. Linear Chemicals, S.L.U.
  • 15.8. Maccura Biotechnology Co., Ltd.
  • 15.9. Seleo S.R.L.
  • 15.10. Thermo Fisher Scientific, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer